Germany · Delayed Price · Currency is EUR Psyched Wellness Statistics
Total Valuation
FRA:5U9 has a market cap or net worth of EUR 2.67 million. The enterprise value is 599,143.
| Market Cap | 2.67M |
| Enterprise Value | 599,143 |
Important Dates
The next estimated earnings date is Friday, January 30, 2026.
| Earnings Date | Jan 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 288.82M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +12.39% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.76% |
| Owned by Institutions (%) | n/a |
| Float | 141.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.93 |
| PB Ratio | 0.99 |
| P/TBV Ratio | 1.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.22 |
| EV / Sales | 2.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.25
| Current Ratio | 11.25 |
| Quick Ratio | 8.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -72.63% and return on invested capital (ROIC) is -44.75%.
| Return on Equity (ROE) | -72.63% |
| Return on Assets (ROA) | -42.45% |
| Return on Invested Capital (ROIC) | -44.75% |
| Return on Capital Employed (ROCE) | -101.10% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.06 |
| Inventory Turnover | 0.29 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +56.25% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +56.25% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 45.75 |
| Average Volume (20 Days) | 35,028 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:5U9 had revenue of EUR 224,211 and -2.76 million in losses. Loss per share was -0.01.
| Revenue | 224,211 |
| Gross Profit | 74,762 |
| Operating Income | -2.72M |
| Pretax Income | -2.76M |
| Net Income | -2.76M |
| EBITDA | -2.72M |
| EBIT | -2.72M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 2.09 million in cash and n/a in debt, giving a net cash position of 2.09 million.
| Cash & Cash Equivalents | 2.09M |
| Total Debt | n/a |
| Net Cash | 2.09M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.69M |
| Book Value Per Share | 0.01 |
| Working Capital | 2.65M |
Cash Flow
| Operating Cash Flow | -2.19M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 33.34% |
| Operating Margin | -1,213.43% |
| Pretax Margin | -1,230.81% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:5U9 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.39% |
| Shareholder Yield | -12.39% |
| Earnings Yield | -103.19% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:5U9 has an Altman Z-Score of -2.08 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.08 |
| Piotroski F-Score | 1 |